Genmab GMAB
$50.60 −$0.75 (-1.46%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $50.02 -1.15%
Open$51.57
Prev close$51.35
Day range$50.24 – $51.72
Volume2.90M
Market cap$31.20B
P/E (TTM)43.2
Dividend yield–
Earnings
Average move on report day±2.9%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+5.5%
Worst reaction-5.7%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 5 Nov 2026 | None | ±6.2% | -4.32% | Within range |
| 2026/Q2 | 6 Aug 2026 | None | ±12.1% | +1.95% | Within range |
| 2026/Q1 | 7 May 2026 | None | ±11.1% | -2.98% | Within range |
| 2025/Q4 | 17 Feb 2026 | None | ±4.5% | -0.10% | Within range |
| 2025/Q3 | 6 Nov 2025 | None | ±10.5% | -1.20% | Within range |
| 2025/Q2 | 7 Aug 2025 | None | ±10.3% | +5.49% | Within range |
| 2025/Q1 | 8 May 2025 | None | ±14.1% | -5.73% | Within range |
| 2024/Q4 | 12 Feb 2025 | None | ±14.7% | +4.24% | Within range |
| 2024/Q3 | 6 Nov 2024 | None | ±11.6% | -1.85% | Within range |
| 2024/Q2 | 8 Aug 2024 | None | ±14.0% | +2.31% | Within range |
| 2024/Q1 | 2 May 2024 | None | ±8.7% | -3.58% | Within range |
| 2023/Q4 | 14 Feb 2024 | None | ±11.2% | +4.39% | Within range |
| 2023/Q3 | 7 Nov 2023 | None | ±11.0% | +2.32% | Within range |
| 2023/Q2 | 3 Aug 2023 | None | ±13.3% | -0.76% | Within range |
| 2023/Q1 | 10 May 2023 | None | ±10.4% | +1.95% | Within range |
| 2022/Q4 | 22 Feb 2023 | None | ±13.5% | -3.26% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.19B+16.1% YoY
Operating profit$441.00M-3.9% YoY
Net profit$342.00M-14.7% YoY
Diluted EPS$0.55-14.7% YoY
Free cash flow$509.00M-4.7% YoY
Operating cash flow$520.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin92.7%
Operating margin30.6%
Net margin17.0%
Return on equity12.1%
Return on assets7.3%
Return on invested capital11.1%
Current ratio2.45
Liabilities / assets51.0%
Cash & investments$1.86B
Total debt$5.17B
Net cash (debt)-$3.31B
Free cash flow / sales19.6%
No comments yet — be the first to weigh in on GMAB.
Sign in to join the discussion.